Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status. (Q53223661)
Jump to navigation
Jump to search
scientific article published on 21 May 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status. |
scientific article published on 21 May 2011 |
Statements
Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status. (English)
1 reference
1 reference
Annette Traeger
1 reference
21 May 2011
1 reference
38
1 reference
1580-1581
1 reference
8
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference